Letters Section Editor: Jody W. Zylke, MD, Senior Editor.
Author Affiliations: Mike Rosenbloom Laboratory for Cardiovascular Research, McGill University Health Centre, Montreal, Quebec, Canada (Dr Sniderman; email@example.com); and Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina (Dr Furberg).
To the Editor: The Emerging Risk Factors Collaboration1 (ERFC) reported on the addition of lipid-related markers to total cholesterol and high-density lipoprotein cholesterol (HDL-C) in the prediction of cardiovascular disease. We attempted to replicate the findings of eTable 1, which summarized the 26 studies that compared apolipoprotein B with the cholesterol markers.
Sniderman AD, Furberg CD. Cardiovascular Disease Risk Prediction Factors. JAMA. 2012;308(19):1969. doi:10.1001/jama.2012.14049